The company has received reimbursement approval in the UK for Heylo™, the world’s first digital leakage notification system, and expands its SenSura® Mio ostomy range with two new products. As part of ...
Full year financial results 1 October 2024 - 30 September 2025 Coloplast delivered Q4 organic growth of 7% and an EBIT ...
Coloplast, a global medical device company and market leader in intimate healthcare, has been awarded a contract for ostomy products with Vizient, Inc., the largest healthcare performance improvement ...
MINNEAPOLIS, Sept.18, 2012 /PRNewswire/ --Coloplast announced the U.S. launch of its new ostomy product, SenSura ® Mio, an ostomy pouch that promises a better body fit and a greater feeling of ...
Organic sales rose 7% year on year, in line with consensus and accelerating from 6.7% in the previous nine months. The strongest growth came from Voice and Respiratory Care and Continence Care, both ...
BURLINGAME, CA, UNITED STATES, March 10, 2025 /EINPresswire / -- The Global Ostomy Care Market is expected to grow at 5.47% from 2025 to 2032. The Latest comprehensive Research Report on the Ostomy ...
The "Global Ostomy Care Market (By Type-Colostomy, Urostomy & Ileostomy; By Region-North America, Europe, Asia Pacific & Latin America) Market Outlook 2024" report has been added to ResearchAndMarkets ...
Despite considerable foreign exchange headwinds, Coloplast posted laudable fiscal third-quarter results that featured strength in interventional urology and wound care as non-pandemic procedures ...
The company has received reimbursement approval in the UK for Heylo, the world's first digital leakage notification system, and expands its SenSura® Mio ostomy range with two new products. As part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback